CIMINO, Luca
 Distribuzione geografica
Continente #
NA - Nord America 9.154
AS - Asia 5.186
EU - Europa 3.564
SA - Sud America 1.516
AF - Africa 137
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 7
Totale 19.583
Nazione #
US - Stati Uniti d'America 8.901
SG - Singapore 1.480
HK - Hong Kong 1.312
CN - Cina 1.290
BR - Brasile 1.199
GB - Regno Unito 988
IT - Italia 684
VN - Vietnam 512
SE - Svezia 485
RU - Federazione Russa 302
DE - Germania 254
FI - Finlandia 227
CA - Canada 160
BG - Bulgaria 155
UA - Ucraina 114
AR - Argentina 108
ID - Indonesia 105
TR - Turchia 102
FR - Francia 92
IN - India 63
EC - Ecuador 61
JP - Giappone 53
KR - Corea 49
AT - Austria 45
BD - Bangladesh 39
IQ - Iraq 39
EG - Egitto 38
NL - Olanda 38
MX - Messico 37
ES - Italia 36
CO - Colombia 35
ZA - Sudafrica 34
PL - Polonia 32
CL - Cile 30
PE - Perù 28
IE - Irlanda 23
PY - Paraguay 19
MY - Malesia 18
MA - Marocco 17
UZ - Uzbekistan 17
VE - Venezuela 17
BZ - Belize 16
CZ - Repubblica Ceca 16
UY - Uruguay 16
KE - Kenya 14
LT - Lituania 13
IL - Israele 12
PK - Pakistan 12
AU - Australia 11
BE - Belgio 9
AE - Emirati Arabi Uniti 8
AL - Albania 8
IR - Iran 8
PT - Portogallo 8
SA - Arabia Saudita 8
TH - Thailandia 8
TN - Tunisia 8
DZ - Algeria 7
GT - Guatemala 7
DO - Repubblica Dominicana 6
NP - Nepal 6
NZ - Nuova Zelanda 6
PA - Panama 6
SI - Slovenia 6
EU - Europa 5
KG - Kirghizistan 5
RO - Romania 5
AZ - Azerbaigian 4
CH - Svizzera 4
DK - Danimarca 4
JM - Giamaica 4
KZ - Kazakistan 4
MK - Macedonia 4
PH - Filippine 4
TT - Trinidad e Tobago 4
BO - Bolivia 3
CR - Costa Rica 3
CY - Cipro 3
GE - Georgia 3
HU - Ungheria 3
JO - Giordania 3
KW - Kuwait 3
MN - Mongolia 3
NO - Norvegia 3
OM - Oman 3
AO - Angola 2
CI - Costa d'Avorio 2
CV - Capo Verde 2
GL - Groenlandia 2
LV - Lettonia 2
LY - Libia 2
MU - Mauritius 2
NG - Nigeria 2
PR - Porto Rico 2
PW - Palau 2
SN - Senegal 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
Totale 19.563
Città #
Santa Clara 1.577
Hong Kong 1.305
Fairfield 906
Singapore 890
Ashburn 847
Chandler 459
Houston 449
London 449
Woodbridge 443
Nyköping 386
Southend 364
Seattle 343
Cambridge 299
Wilmington 299
Beijing 268
Ann Arbor 227
Hefei 213
Ho Chi Minh City 204
Helsinki 187
Los Angeles 176
Princeton 173
Jacksonville 166
Sofia 153
Modena 148
New York 148
San Diego 147
Dearborn 139
Toronto 128
The Dalles 112
Hanoi 105
São Paulo 105
Dallas 104
Moscow 101
Buffalo 87
Chicago 72
Jakarta 62
Shanghai 62
Nuremberg 52
Redondo Beach 50
San Jose 47
Seoul 47
Milan 44
Council Bluffs 39
Eugene 38
Rio de Janeiro 38
Rome 37
Columbus 35
Munich 34
Tokyo 34
Salt Lake City 30
Izmir 27
Frankfurt am Main 26
Guangzhou 26
Cairo 25
Warsaw 25
Brasília 24
Curitiba 24
Vienna 24
Haiphong 22
Dublin 21
Porto Alegre 21
Belo Horizonte 20
Biên Hòa 20
Orem 20
Philadelphia 20
Guayaquil 19
Lauterbourg 19
Lima 19
Quito 19
Santiago 19
Denver 17
Kilburn 17
Belize City 16
Elk Grove Village 16
Bologna 15
Brooklyn 15
Redwood City 15
Reggio Emilia 15
Tashkent 15
Turin 15
Baghdad 14
Da Nang 14
Palermo 14
Thái Bình 14
Atlanta 13
Johannesburg 13
Kuala Lumpur 13
Wuhan 13
Bengaluru 12
Boardman 12
Campinas 12
Chiswick 12
Genoa 12
Kent 12
Mexico City 12
Montevideo 12
Paris 12
Phoenix 12
Salvador 12
Stockholm 12
Totale 13.676
Nome #
-463 G/A myeloperoxidase promoter polymorphism in giant cell arteritis 282
Assessment of the Anti-inflammatory Effects of NORFLO® ORO in Acute Relapses of HLA-B27-associated Autoimmune Uveitis: A Multicenter, Randomized, Placebo-controlled, Double-blind Clinical Study 281
Visual loss and other cranial ischaemic complications in giant cell arteritis 280
G/R 241 polymorphism of intercellular adhesion molecule 1 (ICAM-1) is associated with Fuchs uveitis 260
Correlations between histopathological findings and clinical manifestations in biopsy-proven giant cell arteritis 242
Comparison between colour duplex sonography findings and different histological patterns of temporal artery 240
Interferon Alpha-2a for the Treatment of Post-Infectious Uveitis Secondary to Presumed Intraocular Tuberculosis 230
Increased expression of interleukin-22 in patients with giant cell arteritis 229
Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study 228
Higher Frequencies of Lymphocytes Expressing the Natural Killer Group 2D Receptor in Patients With Behçet Disease 223
Histopathologic Findings of Patients With Biopsy-Negative Giant Cell Arteritis Compared to Those Without Arteritis: A Population-Based Study 222
anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumab 222
Is colour duplex sonography-guided temporal artery biopsy useful in the diagnosis of giant cell arteritis? A randomized study 221
Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study 221
Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis 219
Long-term remission in biopsy proven giant cell arteritis: A retrospective cohort study 218
MicroRNA markers of inflammation and remodelling in temporal arteries from patients with giant cell arteritis 218
Ophthalmic manifestations of cat scratch disease 217
Adalimumab in the treatment of immune-mediated diseases 214
Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease 208
The causes of uveitis in a referral centre of Northern Italy 204
Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia 203
Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis 198
PlA1/A2 polymorphism of the platelet glycoprotein receptor IIIA and risk of cranial ischemic complications in giant cell arteritis 198
Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis—Report 2: Guidelines for Initiating Antitubercular Therapy in Anterior Uveitis, Intermediate Uveitis, Panuveitis, and Retinal Vasculitis 190
Searching for viral antibodies and genome in intraocular fluids of patients with Fuchs uveitis and non-infectious uveitis 187
Erratum to: Changes in patterns of uveitis at a tertiary referral center in Northern Italy: analysis of 990 consecutive cases (International Ophthalmology, (2017), 10.1007/s10792-016-0434-x) 187
Tuberculous uveitis, a resurgent and underdiagnosed disease 185
Interleukin-10 promoter polymorphisms in giant cell arteritis 183
Small-vessel vasculitis surrounding an uninflamed temporal artery and isolated vasa vasorum vasculitis of the temporal artery: two subsets of giant cell arteritis 182
Standardization of red flags for referral to rheumatologists and ophthalmologists in patients with rheumatic diseases and ocular involvement: a consensus statement 179
The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases 179
Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study 177
Association Between Specimen Length and Number of Sections and Diagnostic Yield of Temporal Artery Biopsy for Giant Cell Arteritis 177
Assessment of disease activity in large-vessel vasculitis: Results of an international delphi exercise 171
Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis—Report 1: Guidelines for Initiating Antitubercular Therapy in Tubercular Choroiditis 170
Flares in Biopsy-Proven Giant Cell Arteritis in Northern Italy: Characteristics and Predictors in a Long-Term Follow-Up Study 167
Quasi cieco all'improvviso 162
Ebv-driven lymphoproliferative disorders and lymphomas of the gastrointestinal tract: A spectrum of entities with a common denominator (part 3) 162
The therapeutic potential of tuftsin-phosphorylcholine in giant cell arteritis 160
Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative 158
Anterior ischaemic optic neuropathy in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome): a case report and review of the literature 157
Ebv-driven lymphoproliferative disorders and lymphomas of the gastrointestinal tract: A spectrum of entities with a common denominator (part 2) 152
Effectiveness of Infliximab and Interferon Alpha-2a for the Treatment of Behçet’s Uveitis: Customizing Therapy according to the Clinical Features 151
Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial 148
Toll-like receptor 4 (TLR4) gene polymorphisms in giant cell arteritis 143
Cutaneous Involvement in Diseases with Plasma Cell Differentiation: Diagnostic Approach 136
Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: A population-based study 134
Clinical Features and Prevalence of Spondyloarthritis in a Cohort of Italian Patients Presenting with Acute Nongranulomatous Anterior Uveitis 133
Distribution patterns of 18F-fluorodeoxyglucose in large vessels of Takayasu's and giant cell arteritis using positron emission tomography 131
Autoimmune uveitis in children: clinical correlation between antinuclear antibody positivity and ocular recurrences 129
Aqueous Humor Analysis in Overlapping Clinical Diagnosis of Cytomegalovirus and Rubella Virus Anterior Uveitis 127
miR-146a and miR-146b regulate the expression of ICAM-1 in giant cell arteritis 127
Assessment and classification of choroidal vasculitis in posterior uveitis using indocyanine green angiography 124
Abatacept for Severe Anti-Tumor Necrosis Factor alpha Refractory Juvenile Idiopathic Arthritis-Related Uveitis 123
Interleukin-6 promoter polymorphism at position -174 in giant cell arteritis 121
Uveitis and other ocular complications following covid-19 vaccination 120
Interferon Alpha-2a Treatment for Post-Uveitic Refractory Macular Edema 119
Relapses and long-term remission in large vessel giant cell arteritis in northern Italy: Characteristics and predictors in a long-term follow-up study 116
Reggio Emilia (Northern Italy) Interdisciplinary Uveitis Clinic: What We Have Learned in the Last 20 Years 115
Corrigendum to: Increased expression of interleukin-22 in patients with giant cell arteritis 114
Clinical features and outcomes of patients with tubercular uveitis treated with antitubercular therapy in the collaborative ocular tuberculosis study (COTS)-1 113
Clinical Relevance of Subcentimetric Lymph Node Biopsy in the Diagnosis of Ocular Sarcoidosis 111
Vogt–Koyanagi–Harada patients show higher frequencies of circulating NKG2Dpos NK and NK T cells 111
Assessement and classification of choroidal vasculitis in intraocular inflammation using indocyanine green angiography 111
Uveitis in Tumor Patients Treated with Immunological Checkpoint- and Signal Transduction Pathway-Inhibitors 111
Testo-atlante sulle Uveiti 109
Cytokine Profiling in Aqueous Humor Samples From Patients With Non-Infectious Uveitis Associated With Systemic Inflammatory Diseases 107
Survival and Recurrence in Vitreoretinal Lymphoma Simulating Uveitis at Presentation: The Possible Role of Combined Chemotherapy 107
Acute zonal occult outer retinopathy complex disease: Lessons learned about choroid, photoreceptors, and retinal function 107
Infantile-Onset Spinocerebellar Ataxia Type 5 (SCA5) with Optic Atrophy and Peripheral Neuropathy 107
Role of miR-146a and miR-146b in Giant Cell Arteritis. 105
Efficacy of Rituximab Treatment in Vogt-Koyanagi-Harada Disease Poorly Controlled by Traditional Immunosuppressive Treatment 104
Cataract Surgery with Intraocular Lens Implantation in Juvenile Idiopathic Arthritis-Associated Uveitis: Outcomes in the Era of Biological Therapy 104
Bromfenac ophthalmic solution 0.09% as an adjunctive therapy to topical steroids after cataract surgery in pseudoexfoliation syndrome 104
Surgical management of post-uveitic epiretinal membranes 102
Insight into giant cell arteritis pathogenesis by NanoString nCounter gene expression profiling in temporal artery biopsies 101
Eosinophilic giant cell arteritis: A different subset of disease? 100
Genes deregulated in giant cell arteritis by Nanostring nCounter gene expression profiling in temporal artery biopsies 98
Twenty-four Month Outcomes in the Collaborative Ocular Tuberculosis Study (COTS)-1: Defining the "Cure" in Ocular Tuberculosis 98
Aqueous tap and rapid diagnosis of cytomegalovirus anterior uveitis: the Reggio Emilia experience 95
Anterior Chamber Inflammation After Cataract Surgery: A Randomized Clinical Trial Comparing Bromfenac 0.09% to Dexamethasone 0.1% 95
Changes in patterns of uveitis at a tertiary referral center in Northern Italy: analysis of 990 consecutive cases 94
Yag laser iridotomy in pigment dispersion syndrome: 10 years later 94
Fluorescein angiography findings in eyes with lamellar macular hole and epiretinal membrane foveoschisis 93
Beta-adrenergic antagonists in the treatment of glaucoma 91
Consensus Recommendations for the Diagnosis of Vitreoretinal Lymphoma 90
Interleukin-6 expression in inflamed and non-inflamed temporal arteries from patients with giant cell arteritis 90
Unilateral Ocular Pseudopemphigoid in a Patient With Glaucoma 90
Scoring of dual fluorescein and ICG inflammatory angiographic signs for the grading of posterior segment inflammation (dual fluorescein and ICG angiographic scoring system for uveitis) 90
Ocular inflammatory events following COVID-19 vaccination: a multinational case series 88
Cogan’s syndrome 87
From A… to… Z(OOR): The Clinical Spectrum of Acute Zonal Occult Outer Retinopathy 84
Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL III 84
Retinocoroidopatia tipo Birdshot 84
The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Review of 447 Patients with Tubercular Intermediate Uveitis and Panuveitis 84
The Collaborative Ocular Tuberculosis Study (COTS) Consensus (CON) Group Meeting Proceedings 80
Tubercular Uveitis: Nuggets from Collaborative Ocular Tuberculosis Study (COTS)-1 80
The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Review of 165 Patients with Tubercular Anterior Uveitis 80
67-Galium (67Ga) Scan in Sarcoid Uveitis 79
Totale 14.836
Categoria #
all - tutte 110.610
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.610


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021767 0 0 0 0 0 90 106 173 84 132 96 86
2021/20221.865 47 92 97 58 19 67 449 59 197 53 443 284
2022/20231.776 278 178 176 93 147 219 34 171 203 23 110 144
2023/20241.788 35 73 74 100 390 131 66 225 296 97 56 245
2024/20255.374 95 46 75 337 1.158 840 495 239 685 294 330 780
2025/20265.157 556 376 1.082 1.538 904 701 0 0 0 0 0 0
Totale 19.837